Abstract:Influenza A viruses (IAVs) pose a significant global threat to human health. A tightly controlled host immune response is critical to avoid any detrimental effects of IAV infection. It is critical to investigate the association between the response of Toll-like receptors (TLRs) and influenza virus. Because TLRs may act as a double-edged sword, a balanced TLR response is critical for the overall benefit of the host. Consequently, a thorough understanding of the TLR response is essential for targeting TLRs as a novel therapeutic and prophylactic intervention. To date, a limited number of studies have assessed TLR and IAV interactions. Therefore, further research on TLR interactions in IAV infection should be conducted to determine their role in host–virus interactions in disease causation or clearance of the virus. Although influenza virus vaccines are available, they have limited efficacy, which should be enhanced to improve their efficacy. In this study, we discuss the current status of our understanding of the TLR response in IAV infection and the strategies adopted by IAVs to avoid TLR-mediated immune surveillance, which may help in devising new therapeutic or preventive strategies. Furthermore, recent advances in the use of TLR agonists as vaccine adjuvants to enhance influenza vaccine efficacy are discussed.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to gain an in - depth understanding of the molecular mechanisms of Toll - like receptors (TLRs) in influenza A virus (IAV) infection and how influenza viruses avoid TLR - mediated immune surveillance. Specifically, the paper explores the following aspects: 1. **The role of TLRs in influenza virus infection**: - The paper discusses the activation of downstream signaling pathways after TLRs recognize viral proteins or nucleic acids in influenza virus infection, ultimately leading to the production of pro - inflammatory cytokines, chemokines, and interferons. These responses can enhance the immunopathological process or inhibit viral replication. - Special attention is paid to the changes in the expression of TLR2, TLR3, TLR7, TLR8, and TLR9 in influenza virus infection and their impact on viral load and disease severity. 2. **The role of TLRs in the pathological process**: - The paper analyzes the role of TLRs in the pathological process caused by influenza virus infection, such as the relationship between the TLR3 signaling pathway and the increase in inflammatory response, and the relationship between TLR4 response and acute lung injury. - The impact of dysregulated TLRs expression on the host immune response is studied, especially the differences in young adults and aged mice. 3. **Strategies for treating influenza infection targeting TLR signaling pathways**: - The potential methods of protecting the host from influenza virus infection through agonists of receptors such as TLR2, TLR3, and TLR7 are explored. - For example, the antiviral effects of TLR2 agonist Pam2Cys and TLR7 agonist imiquimod in mouse models. 4. **Mechanisms by which influenza viruses evade the immune response**: - The paper describes in detail how influenza viruses inhibit or evade the host's innate immune response through multiple mechanisms, such as the HA protein promoting the ubiquitination and degradation of IFNAR, and the NS1 protein inhibiting TLR3 - mediated immune responses. - The roles of host restriction factors such as SOX4, SOCS1, and SOCS3 in influenza virus infection are also discussed. 5. **The application of TLR agonists as adjuvants for influenza vaccines**: - The paper reviews the research progress of TLR agonists as vaccine adjuvants, especially their potential in improving vaccine immunogenicity and protective efficacy. - The applications and effects of several TLR agonists (such as TLR4 agonist GLA - SE and TLR7 agonist 1V270) in clinical trials are introduced. In summary, this paper aims to provide theoretical and experimental bases for the development of new treatment and prevention strategies by in - depth study of the mechanism of TLRs in influenza virus infection.

Recent Insights into the Molecular Mechanisms of the Toll-like Receptor Response to Influenza Virus Infection

Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs

Host Innate Antiviral Response to Influenza A Virus Infection: From Viral Sensing to Antagonism and Escape

An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants

Activation of toll-like receptor signaling pathway for protection against influenza virus infection

Host Immune Response to Influenza A Virus Infection

Detrimental Contribution of the Toll-Like Receptor (TLR)3 to Influenza A Virus–Induced Acute Pneumonia

Balancing Immune Protection and Immune Pathology by CD8+ T-Cell Responses to Influenza Infection

Common and Species-Specific Molecular Signatures, Networks, and Regulators of Influenza Virus Infection in Mice, Ferrets, and Humans.

New Insights from an Ex Vivo Model

Comprehensive Transcriptomic Analysis Identifies Novel Antiviral Factors Against Influenza A Virus Infection

Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets

Damage sensing through TLR9 Regulates Inflammatory and Antiviral Responses During Influenza Infection

Taking AIM at Influenza: The Role of the AIM2 Inflammasome

The deadly dance of alveolar macrophages and influenza virus

Innate Immunity and Influenza A Virus Pathogenesis: Lessons for COVID-19

Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell

Damage sensing through TLR9 Promotes Viral Clearance and Recovery During Influenza Infection

Innate immunity to influenza virus infection

Interplay Between Host Non-Coding RNAs and Influenza Viruses

Web of interferon stimulated antiviral factors to control the influenza A viruses replication